EpiCept Corp (EPCT.PK)
EPCT.PK on OTC Markets Group
0.09USD
3:57pm EDT
0.09USD
3:57pm EDT
Price Change (% chg)
$0.01 (+19.44%)
$0.01 (+19.44%)
Prev Close
$0.07
$0.07
Open
$0.08
$0.08
Day's High
$0.09
$0.09
Day's Low
$0.07
$0.07
Volume
544,988
544,988
Avg. Vol
102,954
102,954
52-wk High
$0.19
$0.19
52-wk Low
$0.03
$0.03
About
EpiCept Corporation (EpiCept) is a specialty pharmaceutical company focused on the clinical development and commercialization of pharmaceutical products for the treatment of cancer and pain. It focuses on topically delivered analgesics targeting peripheral nerve receptors and on cancer therapies. Its oncology compounds include... (more)
No analyst recommendations are available for EPCT.PK.
Overall
| Beta: | 1.37 |
| Market Cap (Mil.): | $8.19 |
| Shares Outstanding (Mil.): | 113.75 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| EPCT.PK | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 37.93 | 37.76 |
| EPS (TTM): | -0.03 | -- | -- |
| ROI: | -- | 19.48 | 18.76 |
| ROE: | -- | 20.17 | 19.59 |
Competitors
| Price | Change | |
|---|---|---|
| Pfizer Inc. (PFE.N) | $29.11 | -0.12 |
| Abbott Laboratories (ABT.N) | $36.84 | +0.21 |
| Bayer AG (BAYGn.DE) | €89.43 | +2.08 |
| Bayer AG (BAYE.F) | -- | -- |
| Sanofi SA (SASY.PA) | €76.85 | -3.32 |
| Eli Lilly & Co. (LLY.N) | $53.50 | +0.39 |
| Bristol Myers Squibb Co. (BMY.N) | $43.99 | +0.75 |
| Bristol Myers Squibb Co. (BMYMP.PK) | -- | -- |
| Amgen, Inc. (AMGN.OQ) | $109.45 | +1.16 |
| Endo Health Solutions Inc (ENDP.OQ) | $39.05 | +0.59 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Wright Reports
|
$460.00
|
|
Provider: S&P Capital IQ Factual Report
|
$127.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

